Abstract
MicroRNAs are small non-coding RNAs that are implicated in various biological processes. Hsa-miR-6165 (miR-6165), located in the p75NTR gene, is known to induce apoptosis in human cell lines, but its mechanism of action is not fully understood yet. Here, we predicted the insulin-like growth factor 1 receptor (IGF-1R) gene as a bona fide target for miR-6165. The overexpression of miR-6165 in SW480 cells resulted in significant downregulation of IGF-1R expression as detected by real time quantitative polymerase chain reaction (RT-qPCR) and enzyme-linked immunosorbent assay (ELISA). Also, it resulted in reduced transcript levels of AKT2, AKT3, PI3KR3, PI3KR5, CCND1, c-MYC and P21 genes detected by RT-qPCR analysis. In addition, a direct interaction between miR-6165 and a 3′UTR sequence of the IGF-1R gene was verified through a dual luciferase assay. Furthermore, miR-6165 and IGF-1R showed opposite patterns of expression during the neural differentiation process of NT2 cells. Annexin V analysis and MTT assay showed that miR-6165 overexpression was followed by increased apoptosis and reduced the viability rate of SW480 cells. Moreover, a lower expression level of miR-6165 was detected in high-grade colorectal tumors compared with low-grade tumors. Taken together, the results of our study suggest a tumor suppressive role of miR-6165 in colorectal cancer, which seems to take place by regulating IGF-1R gene expression.
Acknowledgments
Authors thank 4402 laboratory colleagues at TMU. This work has been supported by Tarbiat Modares University and INSF financial aids.
Conflict of interest statement: The authors declare that there are no conflicts of interest with any financial organization regarding the data and material discussed in the article.
References
Adams, B.D., Kasinski, A.L., and Slack, F.J. (2014). Aberrant regulation and function of microRNAs in cancer. Curr. Biol. 24, R762–R776.10.1016/j.cub.2014.06.043Search in Google Scholar
Agarwal, V., Bell, G.W., Nam, J.-W., and Bartel, D.P. (2015). Predicting effective microRNA target sites in mammalian mRNAs. eLife 4, e05005.10.7554/eLife.05005Search in Google Scholar
Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248–254.10.1016/0003-2697(76)90527-3Search in Google Scholar
Carpenter, C.L., Duckworth, B.C., Auger, K.R., Cohen, B., Schaffhausen, B.S., and Cantley, L.C. (1990). Purification and characterization of phosphoinositide 3-kinase from rat liver. J. Biol. Chem. 265, 19704–19711.10.1016/S0021-9258(17)45429-9Search in Google Scholar
Cascieri, M.A. and Bayne, M.L. (1993). Analysis of the interaction of IGF-I analogs with the IGF-I receptor and IGF binding proteins. Adv. Exp. Med. Biol. 343, 33–40.10.1007/978-1-4615-2988-0_4Search in Google Scholar PubMed
Cheng, W., Reiss, K., Kajstura, J., Kowal, K., Quaini, F., and Anversa, P. (1995). Down-regulation of the IGF-1 system parallels the attenuation in the proliferative capacity of rat ventricular myocytes during postnatal development. Lab. Invest. 72, 646–655.Search in Google Scholar
Colussi, D., Brandi, G., Bazzoli, F., and Ricciardiello, L. (2013). Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. Int. J. Mol. Sci. 14, 16365–16385.10.3390/ijms140816365Search in Google Scholar PubMed PubMed Central
Das, F., Dey, N., Bera, A., Kasinath, B.S., Ghosh-Choudhury, N., and Choudhury, G.G. (2016). MicroRNA-214 Reduces insulin-like growth factor-1 (IGF-1) receptor expression and downstream mTORC1 signaling in renal carcinoma cells. J. Biol. Chem. 291, 14662–14676.10.1074/jbc.M115.694331Search in Google Scholar PubMed PubMed Central
Denduluri, S.K., Idowu, O., Wang, Z., Liao, Z., Yan, Z., Mohammed, M.K., Ye, J., Wei, Q., Wang, J., Zhao, L., et al. (2015). Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance. Genes Dis. 2, 13–25.10.1016/j.gendis.2014.10.004Search in Google Scholar PubMed PubMed Central
Duan, L. and Maki, C.G. (2016). The IGF-1R/AKT pathway determines cell fate in response to p53. Transl. Cancer Res. 5, 664–675.10.21037/tcr.2016.09.16Search in Google Scholar PubMed PubMed Central
Elbadawy, M., Usui, T., Yamawaki, H., and Sasaki, K. (2019).Emerging roles of C-Myc in Cancer stem cell-related signaling and resistance to cancer chemotherapy: a potential therapeutic target against colorectal cancer. Int. J. Mol. Sci. 20, 2341.10.3390/ijms20092340Search in Google Scholar PubMed PubMed Central
Elia, L., Contu, R., Quintavalle, M., Varrone, F., Chimenti, C., Russo, M.A., Cimino, V., De Marinis, L., Frustaci, A., Catalucci, D., et al. (2009). Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation 120, 2377–2385.10.1161/CIRCULATIONAHA.109.879429Search in Google Scholar PubMed PubMed Central
Forbes, B.E., Hartfield, P.J., McNeil, K.A., Surinya, K.H., Milner, S.J., Cosgrove, L.J., and Wallace, J.C. (2002). Characteristics of binding of insulin-like growth factor (IGF)-I and IGF-II analogues to the type 1 IGF receptor determined by BIAcore analysis. Eur. J. Biochem. 269, 961–968.10.1046/j.0014-2956.2001.02735.xSearch in Google Scholar PubMed
Gusscott, S., Jenkins, C.E., Lam, S.H., Giambra, V., Pollak, M., and Weng, A.P. (2016). IGF1R derived PI3K/AKT signaling maintains growth in a subset of human T-Cell acute lymphoblastic leukemias. PLoS One 11, e0161158.10.1371/journal.pone.0161158Search in Google Scholar PubMed PubMed Central
Hassanlou, M., Soltani, B.M., and Mowla, S.J. (2017). Expression and function of hsa-miR-6165 in human cell lines and during the NT2 cell neural differentiation process. J. Mol. Neurosci. 63, 254–266.10.1007/s12031-017-0954-5Search in Google Scholar PubMed
He, Z., Cen, D., Luo, X., Li, D., Li, P., Liang, L., and Meng, Z. (2013). Downregulation of miR-383 promotes glioma cell invasion by targeting insulin-like growth factor 1 receptor. Med. Oncol. 30, 557.10.1007/s12032-013-0557-0Search in Google Scholar PubMed
Hixon, M.L., Paccagnella, L., Millham, R., Perez-Olle, R., and Gualberto, A. (2010). Development of inhibitors of the IGF-IR/PI3K/Akt/mTOR pathway. Rev. Recent Clin. Trials. 5, 189–208.10.2174/157488710792007329Search in Google Scholar PubMed
Hu, Q., Lee, S.Y., O’Kusky, J.R., and Ye, P. (2012). Signalling through the type 1 insulin-like growth factor receptor (IGF1R) interacts with canonical Wnt signalling to promote neural proliferation in developing brain. ASN Neuro 4, e00092.10.1042/AN20120009Search in Google Scholar PubMed PubMed Central
Huang, H., Weng, H., Zhou, H., and Qu, L. (2014). Attacking c-Myc: targeted and combined therapies for cancer. Curr. Pharm. Des. 20, 6543–6554.10.2174/1381612820666140826153203Search in Google Scholar PubMed
Karimian, A., Ahmadi, Y., and Yousefi, B. (2016). Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. DNA Repair (Amst.) 42, 63–71.10.1016/j.dnarep.2016.04.008Search in Google Scholar PubMed
Ketting, R.F. (2011). microRNA biogenesis and function: an overview. Adv. Exp. Med. Biol. 700, 1–14.10.1007/978-1-4419-7823-3_1Search in Google Scholar
Kopec, A.M., Rivera, P.D., Lacagnina, M.J., Hanamsagar, R., and Bilbo, S.D. (2017). Optimized solubilization of TRIzol-precipitated protein permits Western blotting analysis to maximize data available from brain tissue. J. Neurosci. Methods 280, 64–76.10.1016/j.jneumeth.2017.02.002Search in Google Scholar PubMed PubMed Central
Krüger, J. and Rehmsmeier, M. (2006). RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic. Acids Res. 34, W451–W454.10.1093/nar/gkl243Search in Google Scholar
Kumar, A.S., Rayala, S.K., and Venkatraman, G. (2018). Targeting IGF1R pathway in cancer with microRNAs: how close are we? RNA Biol. 15, 320–326.10.1080/15476286.2017.1338240Search in Google Scholar
Leevers, S.J., Vanhaesebroeck, B., and Waterfield, M.D. (1999). Signalling through phosphoinositide 3-kinases: the lipids take centre stage. Curr. Opin. Cell Biol. 11, 219–225.10.1016/S0955-0674(99)80029-5Search in Google Scholar
Leichter, A.L., Sullivan, M.J., Eccles, M.R., and Chatterjee, A. (2017). MicroRNA expression patterns and signalling pathways in the development and progression of childhood solid tumours. Mol. Cancer 16, 15.10.1186/s12943-017-0584-0Search in Google Scholar PubMed PubMed Central
Li, Y., Huang, J., Guo, M., and Zuo, X. (2015). MicroRNAs regulating signaling pathways: potential biomarkers in systemic sclerosis. Genom. Proteom. Bioinf. 13, 234–241.10.1016/j.gpb.2015.07.001Search in Google Scholar PubMed PubMed Central
Mora, A., Komander, D., van Aalten, D.M., and Alessi, D.R. (2004). PDK1, the master regulator of AGC kinase signal transduction. Semin. Cell Dev. Biol. 15, 161–170.10.1016/j.semcdb.2003.12.022Search in Google Scholar PubMed
Najdi, R., Holcombe, R.F., and Waterman, M.L. (2011). Wnt signaling and colon carcinogenesis: beyond APC. J. Carcinog. 10, 5.10.4103/1477-3163.78111Search in Google Scholar PubMed PubMed Central
Oberthur, R., Seemann, H., Gehrig, J., Rave-Frank, M., Bremmer, F., Halpape, R., Conradi, L.C., Scharf, J.G., Burfeind, P., and Kaulfuss, S. (2017). Simultaneous inhibition of IGF1R and EGFR enhances the efficacy of standard treatment for colorectal cancer by the impairment of DNA repair and the induction of cell death. Cancer Lett. 407, 93–105.10.1016/j.canlet.2017.08.009Search in Google Scholar PubMed
Paraskevopoulou, M.D., Georgakilas, G., Kostoulas, N., Vlachos, I.S., Vergoulis, T., Reczko, M., Filippidis, C., Dalamagas, T., and Hatzigeorgiou, A.G. (2013). DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows. Nucleic. Acids Res. 41, W169–W173.10.1093/nar/gkt393Search in Google Scholar PubMed PubMed Central
Parsi, S., Soltani, B.M., Hosseini, E., Tousi, S.E., and Mowla, S.J. (2012). Experimental verification of a predicted intronic microRNA in human NGFR gene with a potential pro-apoptotic function. PLoS One 7, e35561.10.1371/journal.pone.0035561Search in Google Scholar PubMed PubMed Central
Ramos-Garcia, P., Gonzalez-Moles, M.A., Ayen, A., Gonzalez-Ruiz, L., Gil-Montoya, J.A., and Ruiz-Avila, I. (2019). Predictive value of CCND1/cyclin D1 alterations in the malignant transformation of potentially malignant head and neck disorders: systematic review and meta-analysis. Head Neck 41, 3395–3407.10.1002/hed.25834Search in Google Scholar PubMed
Rios-Moreno, M.J., Jaramillo, S., Diaz-Delgado, M., Sanchez-Leon, M., Trigo-Sanchez, I., Padillo, J.P., Amerigo, J., and Gonzalez-Campora, R. (2011). Differential activation of MAPK and PI3K/AKT/mTOR pathways and IGF1R expression in gastrointestinal stromal tumors. Anticancer Res. 31, 3019–3025.Search in Google Scholar
Rodriguez, R. and Meuth, M. (2006). Chk1 and p21 cooperate to prevent apoptosis during DNA replication fork stress. Mol. Biol. Cell 17, 402–412.10.1091/mbc.e05-07-0594Search in Google Scholar PubMed PubMed Central
Sakurai, H., Sugimoto, K.J., Shimada, A., Imai, H., Wakabayashi, M., Sekiguchi, Y., Ota, Y., Izutsu, K., Takeuchi, K., Komatsu, N., et al. (2015). Primary CNS CCND1/MYC-positive double-hit B-Cell lymphoma: a case report and review of the literature. J. Clin. Oncol. 33, e79–e83.10.1200/JCO.2013.49.1316Search in Google Scholar PubMed
Shi, Z.M., Wang, X.F., Qian, X., Tao, T., Wang, L., Chen, Q.D., Wang, X.R., Cao, L., Wang, Y.Y., Zhang, J.X., et al. (2013). MiRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas. RNA 19, 552–560.10.1261/rna.035972.112Search in Google Scholar PubMed PubMed Central
Shiratsuchi, I., Akagi, Y., Kawahara, A., Kinugasa, T., Romeo, K., Yoshida, T., Ryu, Y., Gotanda, Y., Kage, M., and Shirouzu, K. (2011). Expression of IGF-1 and IGF-1R and their relation to clinicopathological factors in colorectal cancer. Anticancer Res. 31, 2541–2545.Search in Google Scholar
Siegel, R.L., Miller, K.D., and Jemal, A. (2018). Cancer statistics, 2018. CA Cancer J. Clin. 68, 7–30.10.3322/caac.21442Search in Google Scholar PubMed
Solomon-Zemler, R., Sarfstein, R., and Werner, H. (2017). Nuclear insulin-like growth factor-1 receptor (IGF1R) displays proliferative and regulatory activities in non-malignant cells. PLoS One 12, e0185164.10.1371/journal.pone.0185164Search in Google Scholar PubMed PubMed Central
Subramani, R., Lopez-Valdez, R., Arumugam, A., Nandy, S., Boopalan, T., and Lakshmanaswamy, R. (2014). Targeting insulin-like growth factor 1 receptor inhibits pancreatic cancer growth and metastasis. PLoS One 9, e97016.10.1371/journal.pone.0097016Search in Google Scholar PubMed PubMed Central
Vejnar, C.E., Blum, M., and Zdobnov, E.M. (2013). miRmap web: comprehensive microRNA target prediction online. Nucleic. Acids Res. 41, W165–W168.10.1093/nar/gkt430Search in Google Scholar PubMed PubMed Central
Wu, W.K.K., Wang, X.J., Cheng, A.S.L., Luo, M.X.M., Ng, S.S.M., To, K.F., Chan, F.K.L., Cho, C.H., Sung, J.J.Y., and Yu, J. (2013).Dysregulation and crosstalk of cellular signaling pathways in colon carcinogenesis. Crit. Rev. Oncol. Hematol. 86, 251–277.10.1016/j.critrevonc.2012.11.009Search in Google Scholar PubMed
Xie, M., Zhao, F., Zou, X., Jin, S., and Xiong, S. (2017). The association between CCND1 G870A polymorphism and colorectal cancer risk: a meta-analysis. Medicine (Baltimore) 96, e8269.10.1097/MD.0000000000008269Search in Google Scholar PubMed PubMed Central
Zenonos, K. and Kyprianou, K. (2013). RAS signaling pathways, mutations and their role in colorectal cancer. World J. Gastrointest. Oncol. 5, 97–101.10.4251/wjgo.v5.i5.97Search in Google Scholar PubMed PubMed Central
Zhu, H., Shyh-Chang, N., Segre, A.V., Shinoda, G., Shah, S.P., Einhorn, W.S., Takeuchi, A., Engreitz, J.M., Hagan, J.P., Kharas, M.G., et al. (2011). The Lin28/let-7 axis regulates glucose metabolism. Cell 147, 81–94.10.1016/j.cell.2011.08.033Search in Google Scholar PubMed PubMed Central
©2020 Walter de Gruyter GmbH, Berlin/Boston